author-photo

William E. Barlow

University of Washington
Fred Hutchinson Cancer Research Center
Group Health Cooperative

309

Papers

18292

Citations

Citation Trend

Filter By

Papers (309) Sort By

Journal Conference Others

A randomized trial of fulvestrant, everolimus and anastrozole for the front-line treatment of patients with advanced hormone receptor-positive breast cancer, SWOG S1222.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract GS3-05: Classification of triple negative breast cancer (TNBC) by DNA damage immune response (DDIR) signature and homologous recombination deficiency (HRD) status: Analysis of SWOG S9313 adjuvant trial

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system.

2021 Preventive Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Evaluating Serum Thymidine Kinase 1 in Hormone Receptor Positive Metastatic Breast Cancer Patients Receiving First Line Endocrine Therapy in the SWOG S0226 Trial.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

2021 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Abstract GS4-08: Clinical utility of repeated circulating tumor cell (CTC) enumeration as early treatment monitoring tool in metastatic breast cancer (MBC) - a global pooled analysis with individual patient data

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract GS3-00: First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy (ET) +/- chemotherapy (CT) in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) < 25: SWOG S1007 (RxPonder)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (35)
Abstract PS2-04: Evaluating serum thymidine kinase 1 in hormone receptor positive metastatic breast cancer patients receiving first line endocrine therapy in the SWOG S0226 trial

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials.

2020 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (2)
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).

2020 Supportive Care in Cancer
Show All
- Source
- Cite
- Save
Citations (3)